dc.contributor.author | Casey, L | en_US |
dc.contributor.author | Powell, A | en_US |
dc.contributor.author | Bohm, S | en_US |
dc.contributor.author | Manchanda, R | en_US |
dc.contributor.author | Lockley, M | en_US |
dc.contributor.author | Kobel, M | en_US |
dc.contributor.author | Singh, N | en_US |
dc.date.accessioned | 2020-11-25T11:48:48Z | |
dc.date.issued | 2020 | en_US |
dc.identifier.issn | 0893-3952 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68674 | |
dc.format.extent | 1024 - 1024 | en_US |
dc.title | Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518328902210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | SUPPL 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 33 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | Discovering new therapies for chemotherapy resistant high grade serous ovarian cancer::Barts and The London Charity | en_US |